Related Experiment Video
Updated: Aug 8, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Heparin-induced hyperkalemia confirmed by drug rechallenge
M P Orlando1, M E Dillon, M W O'Dell
1Department of Internal Medicine, University of Cincinnatti College of Medicine, Ohio, USA.
Abstract:
Subcutaneous heparin is commonly used as a prophylaxis against deep venous thrombosis in a wide variety of hospitalized patients. As with most medications, heparin has a significant side effect profile; heparin-induced hyperkalemia is an unusual but well described side effect. To increase awareness of heparin-induced hyperkalemia and of those patients at greatest risk, we present two cases of documented hyperkalemia induced by heparin and reconfirmed by drug rechallenge.
More Related Videos
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
08:11Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Related Concept Videos
Drug Elimination by Renal Route: Tubular Reabsorption
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Drug Toxicity: Allergic Reactions
Drug toxicity: Idiosyncratic Reactions